CAS 148185-52-8

(T-4)-[3,5-dimethyl-2-[[5-(4-phenyl-1,3-butadienyl)-2H-pyrrol-2-ylidene]methyl]-1H-pyrrolato-N¹,N²]difluoro-boron

CAS : 148185-52-8

Formule : C₂₁H₁₉BF₂N₂

Masse moléculaire : 348.1968

Ref: IN-DA01LJ4S

PBD-BODIPY

CAS : 148185-52-8

PBD-BODIPY: a probe for measuring autoxidation. Quantifies by absorbance loss at 591nm; assesses radical-trapping antioxidants and epoxidation activity.

Formule : C₂₁H₁₉BF₂N₂

Couleur et forme : Solid

Masse moléculaire : 348.2

Ref: TM-T35957

PBD-BODIPY

CAS : 148185-52-8

PBD-BODIPY is an inhibitor that has been developed for use in cancer treatment. It is a potent and selective inhibitor of tumor cell growth, inducing apoptosis in cancer cells. PBD-BODIPY targets specific kinases that are involved in the growth and proliferation of cancer cells, inhibiting their activity and preventing further growth. This drug has also shown promising results when used in combination with other anticancer agents such as artesunate or linezolid. Studies have shown that PBD-BODIPY is effective against various types of human cancer cells including Chinese hamster ovary cells, and has been detected in urine after administration, indicating its potential for clinical use.

Formule : C₂₁H₁₉BF₂N₂

Degré de pureté : Min. 95%

Masse moléculaire : 348.2 g/mol

Ref: 3D-YFA18552